September 5, 2015
Prevacus

Photo:

Jacob VanLandingham

Profile

Prevacus

| 2/22/2013

Neuroscientist Jacob VanLandingham, an assistant professor at Florida State University's college of medicine, began research in 2004 to develop a drug to treat concussions. "We recognized within the last few years between military and sports injuries, that concussions have become an epidemic, so we made an effort to find something for this population." The result: VanLandingham recently patented a neurosteroid drug and launched a company, Prevacus, at Tallahassee’s Innovation Park, for work on funding, preclinical trials and product refinement. The development has sparked interest from the Department of Defense and from the University of Pittsburgh Medical Center, a professional sports affiliate that has agreed to help with clinical trials, which could begin within the next 18 to 36 months.

Tags: Trendsetters, Healthcare, Research & Development

Digital Access

DIRECT DIGITAL ACCESS
Add digital to your current subscription, purchase a single digital issue, or start a new subscription to Florida Trend.

TABLE OF CONTENTS
An overview of the features and articles in this month's issue of Florida Trend.

ACCESS THIS ISSUE »

Florida Business News

Florida Trend Video Pick

Virtual Tour of Tampa International Airport Expansion
Virtual Tour of Tampa International Airport Expansion

From the rental car center to people mover to baggage claim, Tampa International Airport takes you on a virtual tour through its historic Master Plan expansion.

Earlier Videos | Viewpoints@FloridaTrend

Ballot Box

Will you labor on Labor Day?

  • Yes, I work on Labor Day.
  • I won't be working, but have a lot of stuff to do.
  • No, looking forward to a day off, relaxing!

See Results

Ballot Box
Subscribe